Mark Nunes

Mark Nunes

Company: Kaiser Permanente LAMC

Job title: Division Chief, Medical Genetics


13.30 | 10.30 – Liquid Biopsy Assay Screening in: A Payor’s Perspective 1:30 pm

The critical importance of assay sensitivity and specificity to act as a decision maker, not descriptive assets How can clinical utility of translational genomics be better demonstrated to payors? Kaiser Permanente assay approval process: what are payors looking for to cover assays within policy? Where are cell free tumor DNA assays most needed clinically?Read more

day: Day Three

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.